BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2375782)

  • 1. Absence of familial defective apolipoprotein B-100 in Finnish patients with elevated serum cholesterol.
    Hämäläinen T; Palotie A; Aalto-Setälä K; Kontula K; Tikkanen MJ
    Atherosclerosis; 1990 Jun; 82(3):177-83. PubMed ID: 2375782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial defective apolipoprotein B-100: a lesson from homozygous and heterozygous patients.
    Ceska R; Vrablík M; Horínek A
    Physiol Res; 2000; 49 Suppl 1():S125-30. PubMed ID: 10984082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a heterozygous compound individual with familial hypercholesterolemia and familial defective apolipoprotein B-100.
    Rauh G; Schuster H; Fischer J; Keller C; Wolfram G; Zöllner N
    Klin Wochenschr; 1991 May; 69(7):320-4. PubMed ID: 2067318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial defective apolipoprotein B-100 is clinically indistinguishable from familial hypercholesterolemia.
    Defesche JC; Pricker KL; Hayden MR; van der Ende BE; Kastelein JJ
    Arch Intern Med; 1993 Oct; 153(20):2349-56. PubMed ID: 8215738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial defective apolipoprotein B100: clinical characteristics of 54 cases.
    Rauh G; Keller C; Kormann B; Spengel F; Schuster H; Wolfram G; Zöllner N
    Atherosclerosis; 1992 Feb; 92(2-3):233-41. PubMed ID: 1632851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial defective apolipoprotein B-100: a common cause of primary hypercholesterolemia.
    Rauh G; Keller C; Schuster H; Wolfram G; Zöllner N
    Clin Investig; 1992 Jan; 70(1):77-84. PubMed ID: 1600334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased binding of apolipoprotein (a) to familial defective apolipoprotein B-100 (Arg3500-->Gln). A study of the assembly of recombinant apolipoprotein (a) with mutant low density lipoproteins.
    Durovic S; März W; Frank S; Scharnagl H; Baumstark MW; Zechner R; Kostner GM
    J Biol Chem; 1994 Dec; 269(48):30320-5. PubMed ID: 7982944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial defective apolipoprotein B-100: a single mutation that causes hypercholesterolemia and premature coronary artery disease.
    Tybjaerg-Hansen A; Humphries SE
    Atherosclerosis; 1992 Oct; 96(2-3):91-107. PubMed ID: 1466657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial defective apolipoprotein B-100: haplotype analysis of the arginine(3500)----glutamine mutation.
    Rauh G; Schuster H; Fischer J; Keller C; Wolfram G; Zöllner N
    Atherosclerosis; 1991 Jun; 88(2-3):219-26. PubMed ID: 1892487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial defective apo B-100, characterization of an Italian family.
    Corsini A; McCarthy BJ; Granata A; Soria LF; Fantappiè S; Bernini ; Romano C; Romano L; Fumagalli R; Catapano AL
    Eur J Clin Invest; 1991 Aug; 21(4):389-97. PubMed ID: 1936106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100.
    Soria LF; Ludwig EH; Clarke HR; Vega GL; Grundy SM; McCarthy BJ
    Proc Natl Acad Sci U S A; 1989 Jan; 86(2):587-91. PubMed ID: 2563166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial defective apolipoprotein B-100. Comparison with familial hypercholesterolemia in 18 cases detected in Munich.
    Schuster H; Rauh G; Kormann B; Hepp T; Humphries S; Keller C; Wolfram G; Zöllner N
    Arteriosclerosis; 1990; 10(4):577-81. PubMed ID: 2164382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic expression and frequency of familial defective apolipoprotein B-100 in Belgian hypercholesterolemics.
    Kotze MJ; Peeters AV; Langenhoven E; Wauters JG; Van Gaal LF
    Atherosclerosis; 1994 Dec; 111(2):217-25. PubMed ID: 7718024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolaemia.
    Myant NB
    Atherosclerosis; 1993 Dec; 104(1-2):1-18. PubMed ID: 8141833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid diagnosis of familial defective apolipoprotein B-100 by Amplification Refractory Mutation System.
    Wenham PR; Newton CR; Houlston RS; Price WH
    Clin Chem; 1991 Nov; 37(11):1983-7. PubMed ID: 1934475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial defective apolipoprotein B-100: enhanced binding of monoclonal antibody MB47 to abnormal low density lipoproteins.
    Weisgraber KH; Innerarity TL; Newhouse YM; Young SG; Arnold KS; Krauss RM; Vega GL; Grundy SM; Mahley RW
    Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9758-62. PubMed ID: 3200853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial defective apolipoprotein B-100.
    Hansen PS
    Dan Med Bull; 1998 Sep; 45(4):370-82. PubMed ID: 9777289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial defective apolipoprotein B-100 (R3500Q) in Northern Ireland.
    McClean E; Graham CA; Ward AJ; Young IS; Martin S; Nicholls DP
    Br J Biomed Sci; 1999; 56(4):258-62. PubMed ID: 10795369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial hypercholesterolemia and familial defective apolipoprotein B-100: comparison of the phenotypic expression In 116 cases.
    Brugger D; Schuster H; Zöllner N
    Eur J Med Res; 1996 May; 1(8):383-6. PubMed ID: 9360938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.